Better Biomarkers for Pancreatic Diseases.
作者信息
Whitcomb David C
机构信息
From the Departments of Medicine, Cell Biology & Molecular Physiology, and Human Genetics, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh/UPMC, Pittsburgh, PA.
出版信息
Pancreas. 2015 Nov;44(8):1171-3. doi: 10.1097/MPA.0000000000000550.
Abstract
摘要
相似文献
1
Better Biomarkers for Pancreatic Diseases.用于胰腺疾病的更好生物标志物。
Pancreas. 2015 Nov;44(8):1171-3. doi: 10.1097/MPA.0000000000000550.
2
Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases.基因检测。咨询、实验室及监管问题以及欧盟胰腺疾病遗传研究多中心伦理研究的EUROPAC方案。
Med Clin North Am. 2000 May;84(3):575-88, viii. doi: 10.1016/s0025-7125(05)70241-8.
3
Magnetic resonance cholangiopancreatography.磁共振胆胰管造影
Semin Roentgenol. 2008 Oct;43(4):282-9. doi: 10.1053/j.ro.2008.06.004.
4
Squeezing data from pancreatic juice.从胰液中提取数据。
不过需要说明的是，这个原文表述比较奇特，正常情况下应该说的是从胰液中提取物质等，“提取数据”在这个语境不太符合常理，如果这不是笔误的话，需要结合更具体的背景来准确理解。
Cancer Biol Ther. 2006 Oct;5(10):1390-1. doi: 10.4161/cbt.5.10.3486. Epub 2006 Oct 26.
5
Pancreas divisum and acute or chronic pancreatitis.胰腺分裂与急慢性胰腺炎。
JOP. 2012 Jan 10;13(1):118-9.
6
Pancreatic disease: recent advances.胰腺疾病：最新进展
Eur J Gastroenterol Hepatol. 1999 Jan;11(1):33-6. doi: 10.1097/00042737-199901000-00007.
7
Hereditary pancreatitis in children: surgical implications with special regard to genetic background.儿童遗传性胰腺炎：特别考虑遗传背景的手术意义。
J Pediatr Surg. 2009 Nov;44(11):2078-82. doi: 10.1016/j.jpedsurg.2009.05.023.
8
New insights into hereditary pancreatitis.遗传性胰腺炎的新见解
Curr Gastroenterol Rep. 1999 Apr;1(2):154-60. doi: 10.1007/s11894-996-0015-7.
9
[Magnetic resonance imaging of the pancreas: value and limits].
Gastroenterol Clin Biol. 2003 May;27(5 Suppl):B57-62.
10
Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis due to serine protease inhibitor kazal type 1 and cystic fibrosis transmembrane conductance regulator mutations.
Pancreas. 2010 Aug;39(6):947-8. doi: 10.1097/MPA.0b013e3181d78d04.
引用本文的文献
1
Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers.胰腺炎：TIGAR-O 版本 2 风险/病因学清单，附有主题综述、更新和使用入门。
Clin Transl Gastroenterol. 2019 Jun;10(6):e00027. doi: 10.14309/ctg.0000000000000027.
2
Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.慢性胰腺炎患者的营养与炎症生物标志物。
Nutr Clin Pract. 2019 Jun;34(3):387-399. doi: 10.1002/ncp.10186. Epub 2018 Aug 13.
3
Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target.激活素在急性胰腺炎中的作用：潜在的风险分层标志物和新的治疗靶点。
Sci Rep. 2017 Oct 6;7(1):12786. doi: 10.1038/s41598-017-13000-3.
4
Peering Into the "Black Box" of the Complex Chronic Pancreatitis Syndrome.深入探究复杂慢性胰腺炎综合征的“黑匣子”。
Pancreas. 2016 Nov;45(10):1361-1364. doi: 10.1097/MPA.0000000000000715.
5
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.胰腺癌化学预防转化研讨会：会议报告
Pancreas. 2016 Sep;45(8):1080-91. doi: 10.1097/MPA.0000000000000705.
本文引用的文献
1
Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.用于胰腺疾病生物标志物开发的生物医学成像、生物工程及相关技术进展：美国国立糖尿病、消化和肾脏疾病研究所与国立生物医学成像和生物工程研究所研讨会总结
Pancreas. 2015 Nov;44(8):1185-94. doi: 10.1097/MPA.0000000000000552.
2
Genetics and Genetic Testing in Pancreatic Cancer.胰腺癌的遗传学和基因检测。
Gastroenterology. 2015 Oct;149(5):1252-1264.e4. doi: 10.1053/j.gastro.2015.07.057. Epub 2015 Aug 6.
3
The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.普通胰凝乳蛋白酶原C（CTRC）变体G60G（C.180T）增加北美人群慢性胰腺炎的风险，但不增加复发性急性胰腺炎的风险。
Clin Transl Gastroenterol. 2015 Jan 8;6(1):e68. doi: 10.1038/ctg.2014.13.
4
Genetic risk factors for pancreatic disorders.胰腺疾病的遗传风险因素。
Gastroenterology. 2013 Jun;144(6):1292-302. doi: 10.1053/j.gastro.2013.01.069.
5
Roles for KRAS in pancreatic tumor development and progression.KRAS 在胰腺肿瘤发生和发展中的作用。
Gastroenterology. 2013 Jun;144(6):1220-9. doi: 10.1053/j.gastro.2013.01.071.
6
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.生物标志物与替代终点：首选定义及概念框架
Clin Pharmacol Ther. 2001 Mar;69(3):89-95. doi: 10.1067/mcp.2001.113989.
7
Hereditary pancreatitis: new insights into acute and chronic pancreatitis.遗传性胰腺炎：对急性和慢性胰腺炎的新见解。
Gut. 1999 Sep;45(3):317-22. doi: 10.1136/gut.45.3.317.
8
Chronic pancreatitis.慢性胰腺炎
N Engl J Med. 1995 Jun 1;332(22):1482-90. doi: 10.1056/NEJM199506013322206.
Zotero 插件